Protheragen Expands Global Partnering Activities at BIO 2026 San Diego

From June 22-25 in San Diego, Protheragen actively participated in the BIO International Convention 2026, where it completed over 120 targeted partnering meetings and strengthened its transaction pipeline with multinational pharmaceutical companies and investment funds.

About BIO International Convention 2026

As one of the world's premier biopharma events, BIO 2026 brought together industry leaders, researchers, BD professionals, and investors under the theme "Driven by Purpose." The convention served as a critical barometer for the sector, reflecting a clear rebound in global deal-making and cross-border collaboration. Over its four-day program, BIO 2026 convened more than 20,000 attendees from 70+ countries and facilitated over 66,000 pre-scheduled partnering meetings. With 1,600+ exhibitors and 150+ conference sessions across 18 thematic tracks, the event stood as one of the largest and most comprehensive biopharma gatherings of the year.

Protheragen & BIO 2026

Protheragen's team maintained a rigorous schedule throughout the four-day convention, completing over 120 one-on-one partnering meetings via the official system. These discussions spanned key markets including North America, Europe, and Asia, engaging BD leaders from multinational pharmaceutical companies, investment funds, and emerging biotech innovators. Beyond the meeting rooms, the team actively participated in core agenda sessions including the AI Summit and BD forums, gaining sharper insights into the latest industry dynamics and future trajectories of the global biopharma sector.

Beyond BIO 2026

Protheragen's participation at BIO 2026 marks the latest milestone in its continuous global BD journey, following its strategic presence at the J.P. Morgan Healthcare Conference and BIO CHINA 2026 earlier this year. This sustained engagement across the industry's premier gatherings reflects Protheragen's unwavering commitment to bridging innovative assets with global partners. As the company moves forward, it will continue to help high-potential projects navigate global market entry and reach their full potential on the international stage.

To learn more about how Protheragen can accelerate your asset's global expansion, please contact us today.